About this trial
Adenosine is a commonly used pharmaceutical stressor at cardiac magnetic resonance examinations to assess suspected chronic coronary syndrome (CCS). However, several studies have reported that the current use of adenosine does not induce adequate hyperemic response in a substantial number of patients, leading to false diagnostics. The aim of this trial is to investigate the hyperemic effect of the standard dose of adenosine (140 microgram/kg/min) to the high dose of adenosine (210 microgram/kg/min) to improve the diagnostic methods using adenosine as a stressor and ultimately improve treatment decisions and patient prognosis in CCS.
Eligibility criteria
Qualifiers
The subject has given their written consent to participate in the trial.
Are referred to Department of Clinical Physiology, Skåne University Hospital, for suspected or known CCS or heart failure
Matches the inclusion criteria for sex and age (6 females and 6 males from each group in each age decade from 40 to >80 years old)
Matches the inclusion criteria for no known heart failure (group b) or known heart failure (group c)
Disqualifiers
Acute referral (in-house patients)
Clinically unstable
Acute chest pain
Severe or decompensated heart failure
Trial design
Treatments tested in this trial
- Adenosine